Transplant Adherence Program educates kidney recipients about adherence

News provided by

Aug 26, 2010, 15:40 ET

MARKHAM, ON, Aug. 26 /CNW/ - To view this Social Media Release, please enter the following address in your web browser.

http://smr.newswire.ca/en/astellas-pharma-canada-inc/transplant-adherence-program-educates-kidney-recipients

For further information: For a complete listing of social media releases available through CNW Group, please visit our calendar at http://smr.newswire.ca

Organization Profile

Astellas Pharma Canada, Inc.

Also from this source

Astellas Initiates Phase 3 Clinical Study of Fezolinetant for VMS in Women with Breast Cancer Receiving Adjuvant Endocrine Therapy
XTANDI® (enzalutamide) Receives Health Canada Approval as the First and Only Treatment for High-Risk Patients with Non-Metastatic Castration-Sensitive Prostate Cancer (nmCSPC)

Browse News Releases

News Releases Overview

Multimedia Gallery

Multimedia Gallery Overview

Trending Topics

Transplant Adherence Program educates kidney recipients about adherence

News provided by

Organization Profile

Astellas Pharma Canada, Inc.

Related Organization(s)

CNW Enriched News Releases

Contact Cision

Products

About

My Services